Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 21583954 | HCID 21583954 | — |
| Reactant | HCID 86598827 | HCID 86598827 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Product | Methyl Salicylate | HCID 4133 | — |
Reaction Steps
740 Grams of a mixed solvent of ethanol/water/methyl salicylate=60/30/10 was added to 100 g of a polymer solution (polymer concentration: about 42%) substituted with imidazolinium cations obtained as in Example 4, to dissolve the polymer, to obtain a solution having the polymer concentration of 5%. To 100 g of this mixed solution was added 0.5 g of the aforementioned polyglycerolpolyglycidyl ether (described-above) used in Example 4, this was placed into a 100 ml sample bottle, the sample bottle was sealed, the bottle was heated for 1 hour in a constant temperature bath at 70° C. to gelate the material, to obtain the integrated gelated-type patch material (RC1) of the present invention with methyl salicylate-based percutaneous absorption drug absorbed therein.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07470738B2 |
|---|
| Source dataset | uspto-grants-2008_12 |
|---|
| ORD ID | ord-60ee426752024b22b2a553937be5f4dd |
|---|
| Source note | uspto-grants-2008_12 |
|---|